We are live on
!
Find out more
Harris Associates Portfolio holdings
AUM
$75B
1-Year Est. Return
11.27%
This Fund
S&P 500
This Quarter
Est. Return
-1.35%
1 Year Est. Return
+11.27%
3 Year Est. Return
+52.81%
5 Year Est. Return
+73.58%
10 Year Est. Return
+314.39%
AUM
$59.9B
AUM Growth
-$1.16B
(-1.9%)
Cap. Flow
+$311M
Cap. Flow
% of AUM
0.52%
Top 10 Holdings %
Top 10 Hldgs %
35.79%
Holding
142
New
11
Increased
48
Reduced
66
Closed
13
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
American Airlines Group
AAL
|
+$604M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
+$591M |
| 3 |
Comcast
CMCSA
|
+$466M |
| 4 |
CVS Health
CVS
|
+$263M |
| 5 |
American International
AIG
|
+$246M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Infosys
INFY
|
+$543M |
| 2 |
Caterpillar
CAT
|
+$381M |
| 3 |
Harley-Davidson
HOG
|
+$375M |
| 4 |
JPMorgan Chase
JPM
|
+$315M |
| 5 |
Fidelity National Financial
FNF
|
+$314M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 29.27% |
| 2 | Communication Services | 18.93% |
| 3 | Technology | 12.67% |
| 4 | Consumer Discretionary | 12.06% |
| 5 | Industrials | 8.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CLGX
76
DELISTED
Corelogic, Inc.
CLGX
| $172M | 0.29% |
3,802,392
+3,668,100
| +2,731% | +$169M |
|
77
Cummins
CMI
$88.5B
| $160M | 0.27% |
984,736
-723,580
| -42% | -$124M |
|
|
PDCE
78
DELISTED
PDC Energy, Inc.
PDCE
| $151M | 0.25% |
3,082,278
+1,054,345
| +52% | +$55.5M |
|
|
WFT
79
DELISTED
Weatherford International plc
WFT
| $144M | 0.24% |
62,750,974
-6,352,816
| -9% | -$20.3M |
|
80
Under Armour Class C
UA
$2.97B
| $136M | 0.23% |
9,480,468
-529,465
| -5% | -$7.46M |
|
81
Ryanair
RYAAY
$31.1B
| $126M | 0.21% |
+2,559,735
| New | +$123M |
|
82
ADT
ADT
$5.38B
| $115M | 0.19% |
+14,491,835
| New | +$159M |
|
|
83
Fidelity National Financial
FNF
$14.6B
| $111M | 0.19% |
2,889,815
-8,260,722
| -74% | -$314M |
|
84
Live Nation Entertainment
LYV
$42.1B
| $111M | 0.18% |
2,628,937
+50,100
| +2% | +$2.22M |
|
85
Carter's
CRI
$1.45B
| $105M | 0.17% |
1,006,595
-6,600
| -0.7% | -$767K |
|
86
C.H. Robinson
CHRW
$20B
| $104M | 0.17% |
1,114,790
-188,495
| -14% | -$17.4M |
|
87
Gaming and Leisure Properties
GLPI
$13B
| $102M | 0.17% |
3,058,185
+285,990
| +10% | +$9.91M |
|
88
IQVIA
IQV
$40.5B
| $97.1M | 0.16% |
989,232
-54,165
| -5% | -$5.47M |
|
89
Criteo
CRTO
$1.06B
| $92.5M | 0.15% |
3,580,500
-9,300
| -0.3% | -$253K |
|
90
Lamb Weston
LW
$7.51B
| $88.6M | 0.15% |
1,522,558
-15,145
| -1% | -$857K |
|
91
Cenovus Energy
CVE
$51.6B
| $83M | 0.14% |
+9,755,372
| New | +$86M |
|
92
Herc Holdings
HRI
$4.95B
| $82.9M | 0.14% |
1,276,111
-81,229
| -6% | -$5.3M |
|
|
93
JPMorgan Chase
JPM
$950B
| $82.2M | 0.14% |
747,152
-2,781,015
| -79% | -$315M |
|
94
Qorvo
QRVO
$8.09B
| $76.8M | 0.13% |
1,090,380
+1,050,940
| +2,665% | +$79.2M |
|
95
Baker Hughes
BKR
$58B
| $76.7M | 0.13% |
2,761,493
-3,691,057
| -57% | -$113M |
|
96
Blackrock
BLK
$170B
| $60.9M | 0.1% |
112,466
-10,581
| -9% | -$5.81M |
|
97
LivaNova
LIVN
$4.51B
| $55.2M | 0.09% |
623,957
-75
| -0% | -$6.39K |
|
98
Axalta
AXTA
$7.58B
| $52.2M | 0.09% |
1,730,266
-210,947
| -11% | -$6.59M |
|
|
WCC
99
WESCO International
WCC
$16.1B
| $44.2M | 0.07% |
712,075
-1,000
| -0.1% | -$64.4K |
|
100
Bristol-Myers Squibb
BMY
$130B
| $40.5M | 0.07% |
640,206
+148,420
| +30% | +$9.55M |
|
Similar funds
CBU
BC
Harris Associates's Q1 2018 Portfolio in Review
As of Q1 2018, Harris Associates held 142 positions worth $59.9B, down 1.9% from $61.1B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Harris Associates's Q1 2018 filing shows 11 new, 48 increased, 66 reduced and 13 closed positions. Its largest new stake was Regeneron Pharmaceuticals: 1,700,033 shares worth $585M. The largest sale was Infosys, an estimated $543M.
By sector, the portfolio is most concentrated in Financials at 29% of assets, down from 31% a quarter earlier, followed by Communication Services and Technology.
- Harris Associates's largest Q1 2018 buy was Regeneron Pharmaceuticals: 1,700,033 shares worth $585M.
- Harris Associates added most to American Airlines Group in Q1 2018, an estimated $604M increase.
- Harris Associates's biggest Q1 2018 reduction was Caterpillar, cutting an estimated $381M.
- Harris Associates fully exited Infosys in Q1 2018, selling an estimated $543M.
- Harris Associates's ten largest holdings make up 36% of its $59.9B portfolio in Q1 2018.
- Harris Associates opened 11 new positions and closed 13 in Q1 2018.
- Harris Associates's portfolio value fell 1.9% quarter-over-quarter to $59.9B.
Based on Harris Associates's 13F filing for Q1 2018, filed 15 May 2018.